Helping funds go further
Find Innovation and R&D Incentives and Other Support Measures
Reduce R&D costs and accelerate discovery with incentives and project funding support in the Basel Area.
Lower the cost of innovation from day one
Life sciences companies in the Basel Area can benefit from R&D incentives and project funding that cut costs and support innovation. Together, these incentives help companies extend R&D budgets, invest in talent, and move faster from research to commercialization.
Up to 25% cash incentives for R&D costs
Innovation here starts with immediate cash back: the Innovation Incentive Program rebates R&D salaries, equipment depreciation and Swiss clinical trial spend.
10.7%: one of Europe’s lowest corporate tax rates
Lower taxes, bigger growth: 13% down to 10.7% with R&D and patent box, plus 10-year holidays fueling talent, clinical trials and faster market entry.
Deduct up to 50% more of your R&D spend
Push more boundaries in a place where risk is rewarded, with up to 150% total R&D tax deductibility on qualifying Swiss-based research.
Cash incentives for R&D costs
Direct financial support can help companies reduce the cost of conducting R&D activities in the Basel Area. Support measures include:
- Up to 25% cash incentives for eligible R&D costs through the Basel-Stadt Innovation Incentive Programme
- Support for R&D personnel costs
- Incentives for laboratory infrastructure and equipment depreciation
- 10% support for eligible Swiss clinical trial costs
Support is structured on a tiered basis, with top rates reaching up to 25% for certain R&D cost categories and 10% for clinical trials.
Additional support is also available for startups in the Basel Area through programs like:
- Basel-Stadt Rent Relief Program
- The Jura’s New Innovative Company (NIE) program, offering financial support for creating management jobs and renting infrastructure.
- Financial support through Innosuisse
One of Switzerland’s most competitive tax structures
At around 13%, the Basel Area’s corporate tax rate is significantly lower than other major Swiss hubs like Zurich (19.61%).
On top of the competitive tax rate, companies in the Basel Area can lower their tax liability with additional support measures like:
- Tax holidays, with temporary tax relief for qualifying investments.
- Patent box regimes, offering reduced taxation on qualifying IP income.
- R&D super deductions, enhanced deductions for eligible Swiss-based R&D spend.
Lab spaces designed for growth
As one of Europe’s leading life sciences hubs, the Basel Area is home to a wide variety of laboratory infrastructure designed to support innovation.
With no shortage of available lab space, companies have their choice of specially designed wet lab and office solutions that help support research activities and evolve alongside their needs.
Project funding pathways
In addition to cost-saving incentives, companies in the Basel Area Life Sciences Supercluster can tap into a broad funding ecosystem, making it easier to identify and access R&D grants and project funding.
Locally, the Basel Area continues to expand support and funding for life sciences research collaborations between companies and regional universities, strengthening industry–academic partnerships.
At the national level, Innosuisse is the primary gateway for innovation funding in Switzerland, supporting collaborative R&D, startup development and applied research. In 2023, it approved CHF 492.2 million in funding.
Key Innosuisse funding pathways include:
- Innosuisse innovation projects: Co-funded R&D with Swiss universities and research institutions
- Startup innovation funding: Up to 70% of eligible project costs covered for early-stage companies
- Swiss Accelerator: Competitive funding for companies scaling market-ready innovations
- Eurostars: International funding for cross-border R&D collaboration
Life science companies can also find additional research and innovation funding opportunities through:
- Eureka: Swiss companies, startups, SMEs, universities and research organizations can participate in Eureka projects, including Eurostars, Clusters and Globalstars calls. For innovative SMEs, Eurostars is often the most relevant instrument for international R&D collaboration.
- Horizon Europe: Switzerland’s renewed association with Horizon Europe enables Swiss entities to participate as full beneficiaries, coordinate projects, and receive funding directly through the program.
- European research partnerships: Companies may also access additional funding through European-aligned programs, collaborative calls and cross-border innovation partnerships.
Together, these programs help companies identify, access and combine funding sources as they build and scale R&D operations in the Basel Area.
Check your grant eligibility
Want to know if your company is eligible for grants and incentives? Book an appointment with our expert.
Incubation support for startups and scale-ups
The Basel Area offers specialized incubation programs that help innovative life sciences companies accelerate growth and strengthen their path to market.
BaseLaunch supports entrepreneurs through tailored programs that help transform scientific breakthroughs into successful businesses.
DayOne brings together healthcare providers, startups, industry partners and innovators to develop and implement solutions that improve delivery.
These initiatives complement the region’s broader life sciences ecosystem by helping startups and scale-ups access expertise, networks and collaboration opportunities.
FAQs
Companies in Basel can access the Basel Incentive Programme, which supports eligible R&D personnel costs, R&D infrastructure depreciation, and Swiss clinical trial costs, with tiered support of 25%, 20%, and 5% depending on the cost band, plus 10% of eligible clinical trial costs.
Yes. Life sciences companies in the Basel Area can access local R&D support, tax incentives, and funding for research collaborations between universities and companies, alongside Switzerland-wide innovation funding through national programs.
No. The Basel-Stadt programme is tiered, not flat. The official overview shows 25% of costs below CHF 5 million, 20% between CHF 5 million and CHF 50 million, and 5% above CHF 50 million for one category, with separate thresholds for other eligible cost types.
Yes. The Basel Incentive Programme includes 10% of eligible clinical trial costs in Switzerland.
Corporate tax rates in the Basel Area are approximately 13%, with Basel-Stadt at around 13.04% and Basel-Landschaft at around 13.45%. This average rate is considerably lower than other Swiss hubs like Zurich (19.61%) and Bern (20.54%).
With R&D incentives and the patent box, effective tax rates in the Basel Area can decrease to as low as 10.7%.
The Basel Incentive Programme provides direct financial support for R&D activities in Basel-Stadt, including personnel, infrastructure and clinical trial costs, with tiered contributions of up to 25% for certain R&D expenses.